loader image
Participate Now

BUILDING THE FOUNDATIONS
OF BIOTECHNOLOGY EXCELLENCE

Participate Now

Visitor Registration

14-16 SEP, 2026
Sofitel Riyadh Hotel & Convention Centre, Riyadh, Saudi Arabia
Days
Hours
Minutes
Seconds
Under the gracious patronage of His Royal Highness
Prince Mohammed bin Salman bin Abdulaziz Al Saud
Crown Prince and Prime Minister
The Riyadh Global Medical Biotechnology Summit 2026 stands as a leading international platform, reflecting the Kingdom’s wise leadership and its commitment to positioning biotechnology as a strategic sector of high developmental and economic value.

SUMMIT
AT A GLANCE

BIOTECH & HEALTHCARE BRANDS (PHARMA | HEALTHCARE | RESEARCH | TECHNOLOGY)
0
GOVERNMENT, LOCAL & GLOBAL EXHIBITORS
0 +
LOCAL & INTERNATIONAL SPEAKERS
0 +
PUBLIC & PRIVATE SECTOR VISITORS
0 K+
WORLDWIDE COUNTRY PARTICIPATION
0 +
AGREEMENTS TO BE SIGNED
0 +

SUMMIT
OVERVIEW

The Riyadh Global Medical Biotechnology Summit 2026 (RGMBS) held under the gracious patronage of His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister and in the presence of His Royal Highness Prince Abdullah bin Bandar bin Abdulaziz Al Saud, Minister of the National Guard. The Summit is organized and overseen by the Ministry of the National Guard, KAIMRC and KSAU-HS.
The Riyadh Global Medical Biotechnology Summit 2026 stands as a leading international platform reflecting the Kingdom’s leadership commitment to positioning biotechnology as a strategic sector with high developmental and economic value. Aligned with Vision 2030 and the National Biotechnology Strategy launched in 2024 by His Royal Highness the Crown Prince May God protect him, the Summit advances innovation localization, strengthens sustainability, and enhances the Kingdom’s global competitiveness across high value biotechnology domains and bio based industries.
RGMBS brings together leaders, policymakers, researchers, and investors to translate scientific innovation into practical, scalable solutions that improve health outcomes and drive economic growth.

FOUR FOUNDATIONAL PILLARS OF BIOTECHNOLOGY EXCELLENCE

The summit is structured around four main pillars that form the backbone of a thriving biotechnology ecosystem. These interconnected elements work synergistically to accelerate innovation, attract global talent, and position the Kingdom as a leader in medical biotechnology.
Governmental Strategies and Regulatory Support

Creating an enabling policy environment

Investment & Funding

Securing capital for breakthrough innovations

R&D Infrastructure
(Pre-clinical and Clinical Readiness)

Building world-class research and manufacturing facilities

Building Capabilities

Cultivating local expertise and attracting global leaders

CONFERENCE
OVERVIEW

The Conference is a high-impact global platform that translates scientific knowledge into practical, implementable solutions. It convenes industry leaders, decision-makers, and investors within an integrated ecosystem that aligns research with funding, regulation with production, and applied validation with commercial-scale biomanufacturing.
Distinguished by a results-driven approach, the conference catalyzes strategic partnerships, advanced technology transfer, and the localization of priority industries, thereby strengthening the Kingdom of Saudi Arabia’s position as a global gateway for medical biotechnology.

EXHIBITION
OVERVIEW

The Exhibition serves as a global platform bringing together government entities, companies, research centers, and international institutions to showcase the latest scientific and technological innovations and solutions, while advancing the Summit’s four pillars: Building Capabilities, Investment & Funding, R&D infrastructure and preclinical and clinical readiness, and governmental strategies and regulatory support.
It features specialized zones including medical biotechnology, scientific discovery, and startups, alongside inspiring experiences that reflect the sector’s breadth and reinforce innovation as a strategic priority. It also creates high-value opportunities for partnerships, investment attraction, and the expansion of international networks, connecting innovators with investors and decision-makers and strengthening the Kingdom’s position as a global hub for biotechnology.

WORKSHOPS
OVERVIEW

The workshops are designed as an intensive, hands-on learning environment that translates scientific concepts into skills that can be applied immediately. Delivered through practical applications and field-based training, supported by specialized lectures and live, interactive sessions, they are led by experts from both the research and industrial ecosystems.
The program covers high-value themes including gene editing, 3D bioprinting, data analytics, and AI in life sciences, as well as the end-to-end drug pipeline (discovery, development, and manufacturing), biomanufacturing practices, and supply chains. The workshops aim to equip participants with clear tools and methodologies and to generate practical outputs that strengthen readiness, accelerate solution adoption, and support scalability.

SUMMIT
OBJECTIVES

01

Align with Vision 2030:

Localize priority technologies and deliver sustainable health and economic value.

02

Advance Global Leadership:

Position the Kingdom as a worldwide hub for biomedical innovation and research.

03

Attract Strategic Investment:

Mobilize national and international capital to accelerate innovation-led growth.

04

Build Strategic Partnerships:

Align efforts to launch measurable joint initiatives and partnerships.

05

Catalyze Innovation:

Enable an ecosystem that turns ideas into scalable, real-world solutions.

06

Strengthen Knowledge Transfer:

Expand awareness of biotechnology’s impact across health.

07

Expand International Collaboration:

Build bridges with leading global universities and research centers.

08

Empower National Talent:

Develop capabilities through specialized training pathways and programs.

01

Align with Vision 2030:

Localize priority technologies and deliver sustainable health and economic value.

02

Advance Global Leadership:

Position the Kingdom as a worldwide hub for biomedical innovation and research.

03

Attract Strategic Investment:

Mobilize national and international capital to accelerate innovation-led growth.

04

Build Strategic Partnerships:

Align efforts to launch measurable joint initiatives and partnerships.

05

Catalyze Innovation:

Enable an ecosystem that turns ideas into scalable, real-world solutions.

06

Strengthen Knowledge Transfer:

Expand awareness of biotechnology’s impact across health.

07

Expand International Collaboration:

Build bridges with leading global universities and research centers.

08

Empower National Talent:

Develop capabilities through specialized training pathways and programs.

HIGHLIGHTED
FEATURES

HOSTED BUYER PROGRAM

HOSTED BUYER PROGRAM

Image
Bringing targeted investors, led by the Ministry of Investment, connecting them with potential exhibitors.
Investor Registration

BIOTECH
CONNECT

BIOTECH
CONNECT

Image
Fostering connections across the biotechnology ecosystem through structured matchmaking meetings.

EXECUTIVE BIOTECH COUNCILS

EXECUTIVE BIOTECH COUNCILS

Image
Convening biotech leaders, investors, and innovators to exchange strategic insights, address industry challenges, and shape the future of life sciences.

EXECUTIVE BIOTECH COURSES

EXECUTIVE BIOTECH COURSES

Image
Equipping decision-makers with advanced strategic, financial, and scientific expertise through executive-level programs tailored to the evolving biotech landscape.

PARTNERS & SPONSORS

Strategic Partner
Hosted by
Sponsors Participation Form
Exhibitors Participation Form